CDC advisers to consider additional coronavirus dose for immunocompromised patients
(Washington Post Health & Science)

An advisory panel next week plans to focus on the 2 to 4 percent of U.S. adults who have suppressed immunity, a population that includes organ transplant recipients, people on cancer treatments and those living with rheumatologic conditions, HIV and leukemia.